FDA Investigator Jonathan G Matrisciano

Jonathan G Matrisciano has conducted inspections on 139 sites in 8 countries as of 03 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
139
Last Inspection Date:
03 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, China, Mexico, Canada, Hong Kong, Spain, India, Argentina
FDA Investigators that have inspected at least one site in common with Jonathan G Matrisciano:
Abby E Pelletier, Abdur Rafay Shareef, Adetutu M Gidado, Aditi S Thakur, Alan P Kurtzberg, Alan R Condon, Alicia M Mozzachio, Althea A Williams, Alyssa R Favro, Amber G Wardwell, Amy C Jordan, Amy M Cramer, Anastasia M Shields, Andre S Lamontagne, Andrew M Barlow, Anita R Michael, Ann Marie Montemurro, Anne E Carpenter, Anthony C Warchut, Anthony J Donato, Anthony P Costello, Anthony W Thomas, Arie C Menachem, Armen H Youssoufian, Ashley L Reiber, Atricia L Irons, Azeezat M Lawal, Azza Talaat, Barbara G Swan, Barbara Jwilimczyk Macri, Barbara M Frazier, Bei Y He, Bo Chi, PhD, Bonita S Chester, Bradley D Newsad, Brandy L Couillard, Brandy N Lepage, Brenda P King, Brenna L Macdowell, Brian D Nicholson, Burnell M Henry, Byungja E Marciante, Camerson E Moore, Carl A Perez, Carla C Cummins, Carla C Tuite, Carolyn A Renshaw, Cassandra L Abellard, Charles I Ann, Charlotte Hinkle, Cheryl A Clausen, Chiang Syin, PhD, Christian F Gomez Lugo, Christina K Theodorou, Christine L Williams, Christopher Janik, Christopher S Keating, Chunchun Zhang, Claire M Minden, Constance Desimone, Cynthia Jim, CSO, Cynthia Whitmarsh, Daniel J Grabicki, Daniel J Min, Daniel L Zheng, Darin S Wiegers, Daryl A Dewoskin, David A Oluwo, David M Lamoureux, David P Vanhouten, Dawn C Olenjack, Dawn M Braswell, Denise L Terzian, Devon Jenkins, Diane C Thibodeau, Diane M Fresch, Diane M Prince, Dien N Nguyen, Dina K West, Dolores Harper, Dominic R Frasca, Donald C Obenhuber, PhD, Donald G Gordon, Dorothy W Lee, Douglas F Frazier, Douglas S Joslin, Dr. Gang Wang, PhD, Dr. Gopa Biswas, PhD, Dr. Robert C Horan, MD, Dr. Willie F Vann, PhD, Dr. Yubing Tang, Edmund F Mrak, Jr, Edward J Janik, Edwin Melendez, Eliezar Ramos, Elise L Mcdevitt, Elizabeth B Griffin, Ellen P Madigan, Eric C Schmitt, Erich P Garger, Farhana Khan, Felix Maldonado, Frank J Koch, Frederick F Razzaghi, Garry H Stewart, Gary J Hagan, George J Flynn, George T Allen, Jr, Gerard D Difiore, Gerard J Desany, Ginger M Sykes, Guo Q Shen, Gwyn G Dickinson, Helen R Bester, Hien Albright, Holly Brevig, Hung H Do, MS, Jacqueline Mdiaz Albertini, James C Maclaughlin, James E Keller, PhD, James Norman, James P Finn, James W Whitney, Janet L Bowen, Jason D Tenney, Jawaid Hamid, Jayaleka J Amarasinghe, Jeffery A Hangartner, Jenny Sung, Jessica I Newman, Jianming Li, Jie He, Joan A Loreng, Joel D Hustedt, John A Sciacchitano, John J Thibodeau, John P Mistler, John P Shelton, John S Hartford, Jonah S Ufferfilge, Jonathan B Lewis, Joppie, Jose A Torres, Jose Acruz Gonzalez, Jose M Cayuela, Jose Martinez, Jr, Joy Rkozlowski Klena, Joyce A Kellett, Juan Rjimenez Garcia, Julie D Bringger, Junho Pak, Justin A Boyd, Justine M Corson, Justine Tomasso, Kalavati Suvarna, PhD, Karen A Briggs, Karen E D'orazio, Karen Mcnabb Noon, Katarzyna Plona, Katherine D Adams, Katherine Szestypalow, Kathleen E Mcafoose, Katie L Korchinski, Kenneth H Williams, Kent A Conforti, Kent C Faul, Kevin A Gonzalez, Kham Phommachanh, Kim Lthomas Cruse, Krystyna M Kitson, Kwong P Lee, Laura L Staples, Lauren M Lawrance, Laurie B Frazier, Laurimer Kuilan Torres, LCDR Chad N Thompson, LCDR Debra Emerson, Leanna M Slarsky, Leonard H Lavi, Leslie D Wagner, Li Yun Huang, Linda L Green, Linda Thai, Lindsey R Lyman, Lisa M Romano, Loretta Nemchik, Lori A Holmquist, Lori M Newman, LT Daveta L Bailey, Luis A Dasta, Marea K Harmon, Margaret E Walsh, Margaret M Doherty, Margaret M Sands, Maria A Reed, Marie A Fadden, Mariza M Jafary, Mark C Lookabaugh, Mark R Mcclain, Martha T Olone, Mary Jeanet Mcgarry, Maryam Tabatabaie, Marybet Lopez Negron, Matthew B Casale, Matthew C Watson, Matthew D Silverman, Maura Rooney, Max Lager, Maya M Davis, Megan A Haggerty, Melanie M Walker, Melinda L Rice, Melkamu Getie Kebtie, PhD, Michael G Mayfield, Michael G Sinkevich, Michael O Idowu, Michael P Anthony, Michael P Sheehan, Michael P Sweeney, Michael R Goga, Michael Schmitt, Michael Serrano, Michelle L Dragon Nagel, Michelle M Noe Varga, Michelle Yclark Stuart, Miguel A Martinez Perez, Mihaly S Ligmond, Mindy M Chou, Nabil Nakhoul, Nancy M Espinal, Nealie C Newberger, Nichole B Murphy, Nicola M Fenty Stewart, Obinna R Echeozo, Ogechi C Nna, Osama A Khatib, Paige R Mccoy, Pamela L Ogonowski, Paraluman S Leonin, Paul L Bellamy, Paul P Geraci, Paula A Trost, Paula M Laplant, Philip H Lafleur, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Raeann R Wu, Raihan A Chowdhury, Rajiv R Srivastava, Ramon E Martinez, Raquel Gonzalez Rivera, Rebecca E Dombrowski, Rebecca Rodriguez, Richard A Abate, Richard B Mcaroy, Richard F Hapke, Richard H Penta, Richard L Licari, Robert C Coleman, Robert J Ham, Robert J Martin, Robert J Veitch, Robert O'brian, Robert W Fisher, Rochelle L Cross, Roger F Zabinski, Ronald A Stokes, Rory K Geyer, Rosario D'costa, Rose Ashley, Rowena S Nguyen, Rupa Pradhan, Russell J Glapion, Russell K Riley, Sam Pepe, Samuel T Walker, Sandra P White, Scott M Loughan, Scott T Ballard, Sean M Tessicini, Sean R Marcsisin, Seongeun Cho (Julia), PhD, Seth A Mailhot, Sharon K Thoma, PharmD, Shirley S Wen, Simone E Pitts, Sony Mathews, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stacey S Degarmo, Stacie A Woods, Stefan Kaszycki, Stephen C Smith, Stephen J Mottola, Stephen R Souza, Stephenie M Ortiz, Suchan Kim, Sunita Pandey, Susan F Laska, MS, Susan M Jackson, Susanne M Richardson, MS RAC, Suzanne M Healy, Tajah L Blackburn, Tamara S Rosbury, Tamil Arasu, PhD, Tanya R Syffrard, Teddy Tom, Teresa I Navas, Terry Bridgewater, Terry C Kimball, Thomas Cote, Thomas J Arista, Thomas J Murphy, Thomas Siebertz, Timothy M Glod, Tonya R Johnson, Towanda L Terrell, Toyin B Oladimeji, Tracy K Li, Truong Xuan Nguyen (Andy), Unnee Ranjan, Uttaniti Limchumroon (Tom), Valentino Fiorella, Vidya B Pai, Vivin George, Wayne D Mcgrath, Wayne E Seifert, Wella Wang, Wendy A Johnecheck, William J Leonard, William M Rennells, Ying Xin Fan, PhD, Yoriann M Cabrera Bartolomei, Youmin Wang, Yvesna C Blaise, Yvins Dezan, Yvonne Y Wu, Ze Peng

Jonathan G Matrisciano's Documents

Publish Date Document Type Title
March, 2023 FDA 483 Fresenius Kabi Compounding, LLC - Form 483, 2023-03-06
January, 2018 EIR Lyne Laboratories, Inc. - EIR, 2018-01-25
September, 2019 FDA 483 Emergent BioSolutions Canada Inc - Form 483, 2019-09-13
May, 2017 FDA 483 Curia Massachusetts, Inc. - Form 483, 2017-05-24
July, 2014 FDA 483 Biogen, Inc. - Form 483, 2014-07-03
August, 2022 FDA 483 BioVectra Inc - Form 483, 2022-08-26
February, 2019 FDA 483 Airgas Usa, LLC - Form 483, 2019-02-14
March, 2017 FDA 483 MassBiologics - Form 483, 2017-03-09
January, 2018 FDA 483 Lyne Laboratories, Inc. - Form 483, 2018-01-25
September, 2019 FDA 483 8046255 Canada Inc - Form 483, 2019-09-24
January, 2019 EIR Veranova, L.P. - EIR, 2019-01-31
February, 2022 FDA 483 Amneal Pharmaceuticals LLC - Form 483, 2022-02-10
September, 2019 EIR Emergent BioSolutions Canada Inc - EIR, 2019-09-13
May, 2024 FDA 483 Brookfield Medical/Surgical Supplies, Inc. - Form 483, 2024-05-10
September, 2022 FDA 483 Sterinova Inc. - Form 483, 2022-09-07
June, 2017 EIR Esteve Quimica, SA - EIR, 2017-06-16
August, 2016 FDA 483 Pharmasol Corporation - Form 483, 2016-08-04
October, 2023 FDA 483 Medical-technical Gases, Inc. - Form 483, 2023-10-12
January, 2020 FDA 483 PHARMARON MANUFACTURING SERVICES (US) LLC - Form 483, 2020-01-23
October, 2017 FDA 483 Response Denison Pharmaceuticals, LLC - Form 483R, 2017-11-06
March, 2018 FDA 483 SCA Pharmaceuticals, LLC - Form 483, 2018-03-05
January, 2020 FDA 483 Response PHARMARON MANUFACTURING SERVICES (US) LLC - Form 483R, 2020-02-12
August, 2023 FDA 483 Berkshire Sterile Manufacturing, Inc. - Form 483, 2023-08-25
January, 2018 FDA 483 Response Lyne Laboratories, Inc. - Form 483R, 2018-02-07
March, 2024 FDA 483 HomeoCare Laboratories Inc. - Form 483, 2024-03-20
October, 2017 FDA 483 Denison Pharmaceuticals, LLC - Form 483, 2017-10-25
April, 2022 FDA 483 New England Life Care, d/b/a Advanced Compounding Solutions - Form 483, 2022-04-28
December, 2022 FDA 483 Northern VA Compounders PLLC - Form 483, 2022-12-09
August, 2019 FDA 483 Roger Williams Medical Center - Form 483, 2019-08-14
May, 2019 FDA 483 ProCaire, Limited Liability Company - Form 483, 2019-05-17
September, 2019 FDA 483 Response Emergent BioSolutions Canada Inc - Form 483R, 2019-10-04
August, 2018 FDA 483 Pharmasol Corporation - Form 483, 2018-09-04
August, 2016 EIR Pharmasol Corporation - EIR, 2016-08-04
October, 2021 FDA 483 Response Johnson Memorial Cancer Center - Form 483R, 2021-11-10
July, 2014 FDA 483 Response Biogen, Inc. - Form 483R, 2014-07-25
October, 2021 FDA 483 Johnson Memorial Cancer Center - Form 483, 2021-10-21
January, 2019 FDA 483 Founders Science Group, LLC - Form 483, 2019-01-10
November, 2019 FDA 483 GF Health Products, Inc. - Form 483, 2019-11-14
April, 2016 FDA 483 Denison Pharmaceuticals, LLC - Form 483, 2016-04-05
July, 2014 EIR Biogen, Inc. - EIR, 2014-07-03
May, 2015 FDA 483 Autumn Harp, Inc. - Form 483, 2015-05-14
February, 2016 FDA 483 Ocular Therapeutix, Inc. - Form 483, 2016-02-11
November, 2020 FDA 483 Hopkinton Drug, Inc. - Form 483, 2020-11-10
January, 2016 FDA 483 New England Home Therapies, Inc - Form 483, 2016-01-27
April, 2016 FDA 483 Denison Pharmaceuticals, LLC - Form 483, 2016-04-05

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more